{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:17:55Z","timestamp":1772687875736,"version":"3.50.1"},"reference-count":168,"publisher":"Elsevier","isbn-type":[{"value":"9780443316487","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.03.004","type":"book-chapter","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:25:04Z","timestamp":1744493104000},"page":"25-56","source":"Crossref","is-referenced-by-count":2,"title":["Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson\u2019s disease (PD)"],"prefix":"10.1016","author":[{"given":"Rahul","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"B","key":"10.1016\/bs.irn.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3889\/oamjms.2021.6649","article-title":"Surgical management of Parkinson\u2019s disease: The role of lesioning procedures in developing countries in the modern era","volume":"9","author":"Abdelbari","year":"2021","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"key":"10.1016\/bs.irn.2025.03.004_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81453","article-title":"A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice","volume":"11","author":"Abdel-Haq","year":"2022","journal-title":"eLife"},{"key":"10.1016\/bs.irn.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson\u2019s disease: Temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"eBioMedicine"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/antibiotics12050868","article-title":"Future modulation of gut microbiota: From eubiotics to FMT, engineered bacteria, and phage therapy","volume":"12","author":"Airola","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/bs.irn.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"1330903","DOI":"10.3389\/fnut.2024.1330903","article-title":"Approach to the diagnosis and management of dysbiosis","volume":"11","author":"Alagiakrishnan","year":"2024","journal-title":"Frontiers in Nutrition"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/1570159X16666180830100754","article-title":"Different generations of type-B monoamine oxidase inhibitors in Parkinson\u2019s disease: From bench to bedside","volume":"17","author":"Alborghetti","year":"2019","journal-title":"Current Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nrl.2011.04.012","article-title":"Dopaminergic agonists in Parkinson\u2019s disease","volume":"29","author":"Alonso C\u00e1novas","year":"2014","journal-title":"Neurologia"},{"issue":"40","key":"10.1016\/bs.irn.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","article-title":"Gut permeability and microbiota in Parkinson\u2019s disease: Role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archneur.62.4.554","article-title":"Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease","volume":"62","author":"Anderson","year":"2005","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha\u2010synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel\u2010Cresswell","year":"2013","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib11","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6895.1000298","article-title":"Parkinson\u2019s disease: A concise overview of etiology, epidemiology, diagnosis, comorbidity and management","volume":"4","author":"Ayano","year":"2016","journal-title":"Journal of Neurological Disorders"},{"issue":"23","key":"10.1016\/bs.irn.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.3390\/s22239242","article-title":"Simultaneous gut-brain electrophysiology shows cognition and satiety specific coupling","volume":"22","author":"Balasubramani","year":"2022","journal-title":"Sensors"},{"issue":"14","key":"10.1016\/bs.irn.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acschemneuro.4c00106","article-title":"Mechanistic insight into intestinal \u03b1-synuclein aggregation in Parkinson\u2019s disease using a laser-printed electrochemical sensor","volume":"15","author":"Balsamo","year":"2024","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Medicine"},{"issue":"12 6","key":"10.1016\/bs.irn.2025.03.004_bib15","first-page":"S13","article-title":"Mechanism of action of deep brain stimulation","volume":"55","author":"Benazzouz","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.3390\/ijms24119577","article-title":"Neurodegenerative and neurodevelopmental diseases and the gut-brain axis: The potential of therapeutic targeting of the microbiome","volume":"24","author":"Bicknell","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2025.03.004_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120193","article-title":"Focused ultrasound and other lesioning in the treatment of tremor","volume":"435","author":"Binder","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib18","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: A mini-review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bpg.2009.02.014","article-title":"Methods and functions: Breath tests","volume":"23","author":"Braden","year":"2009","journal-title":"Best Practice & Research in Clinical Gastroenterology"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/mds.29432","article-title":"The endotoxin hypothesis of Parkinson\u2019s disease","volume":"38","author":"Brown","year":"2023","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2025.03.004_bib21","article-title":"A serotonin story in a toxicological model of Parkinsonism: Real time","author":"Buchanan","year":"2022","journal-title":"In Vivo, Chemical Investigations in Mice"},{"key":"10.1016\/bs.irn.2025.03.004_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fneur.2019.00663","article-title":"Potential of prebiotic butyrogenic fibers in Parkinson\u2019s disease","volume":"10","author":"Cantu-Jungles","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1039\/C4MT00339J","article-title":"Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson\u2019s disease","volume":"7","author":"Carboni","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/bs.irn.2025.03.004_bib24","unstructured":"Chang, C., Ramphul, K. Amantadine. (2023). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 29763128."},{"issue":"16","key":"10.1016\/bs.irn.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.3390\/jcm12165231","article-title":"The impact of microbiota on the gut\u2013brain axis: Examining the complex interplay and implications","volume":"12","author":"Chaudhry","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Experimental & Molecular Medicine"},{"issue":"15","key":"10.1016\/bs.irn.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/CM9.0000000000000330","article-title":"Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure","volume":"132","author":"Chen","year":"2019","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","article-title":"Dopaminergic neurons","volume":"37","author":"Chinta","year":"2005","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5946\/ce.2015.117","article-title":"Fecal microbiota transplantation: Current applications, effectiveness, and future perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clinical Endoscopy"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41598-018-19646-x","article-title":"Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice","volume":"8","author":"Choi","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fphar.2020.00194","article-title":"Striatal dopamine D2-muscarinic Acetylcholine M1 receptor\u2013receptor interaction in a model of movement disorders","volume":"11","author":"Crans","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib32","article-title":"Amantadine in Parkinson\u2019s disease","volume":"2003","author":"Crosby","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib33","article-title":"Amantadine for dyskinesia in Parkinson\u2019s disease","volume":"2003","author":"Crosby","year":"2003"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods8030092","article-title":"Prebiotics: Definition, types, sources, mechanisms, and clinical applications","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Internal and Emergency Medicine"},{"key":"10.1016\/bs.irn.2025.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"21","key":"10.1016\/bs.irn.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","article-title":"Results from a phase I safety trial of hAADC gene therapy for Parkinson disease","volume":"70","author":"Eberling","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11604-017-0714-z","article-title":"Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson\u2019s disease using MEGA-PRESS MRS","volume":"36","author":"Elmaki","year":"2018","journal-title":"Japanese Journal of Radiology"},{"issue":"17","key":"10.1016\/bs.irn.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3390\/ijms20174121","article-title":"Probiotics for Parkinson\u2019s disease","volume":"20","author":"Gazerani","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/nu10060708","article-title":"Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases","volume":"10","author":"Gerhardt","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/bs.irn.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tiv.2017.06.008","article-title":"Neurodegenerative signaling factors and mechanisms in Parkinson\u2019s pathology","volume":"43","author":"Goswami","year":"2017","journal-title":"Toxicology in Vitro"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.celrep.2019.12.078","article-title":"Probiotic bacillus subtilis protects against \u03b1-synuclein aggregation in C. elegans","volume":"30","author":"Goya","year":"2020","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14803-9","article-title":"A hands-free stool sampling system for monitoring intestinal health and disease","volume":"12","author":"Grego","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2025.03.004_bib45","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (review)","author":"Guo","year":"2018","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.irn.2025.03.004_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102013","article-title":"New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson\u2019s disease","author":"Gupta","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.14309\/ajg.0000000000001075","article-title":"Fecal microbiota transplantation: The evolving risk landscape","volume":"116","author":"Gupta","year":"2021","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/bs.irn.2025.03.004_bib48","series-title":"Dietary interventions in gastrointestinal diseases","first-page":"151","article-title":"The role of prebiotics in disease prevention and health promotion","author":"Gyawali","year":"2019"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson\u2019s disease: Is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Experimental Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.004_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta\u2010analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/21597081.2016.1211066","article-title":"The impact of orally administered phages on host immune response and surrounding microbial communities","volume":"6","author":"Hong","year":"2016","journal-title":"Bacteriophage"},{"key":"10.1016\/bs.irn.2025.03.004_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.14802\/jmd.21085","article-title":"Fecal calprotectin in Parkinson\u2019s disease and multiple system atrophy","volume":"15","author":"Hor","year":"2022","journal-title":"Journal of Movement Disorders"},{"key":"10.1016\/bs.irn.2025.03.004_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.615075","article-title":"Review: The role of intestinal dysbiosis in Parkinson\u2019s disease","volume":"11","author":"Huang","year":"2021","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.004_bib56","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acs.chemrestox.2c00193","article-title":"Role of protein damage inflicted by dopamine metabolites in Parkinson\u2019s disease: Evidence, Tools, and outlook","volume":"35","author":"Hurben","year":"2022","journal-title":"Chemical Research in Toxicology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.004_bib58","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000095209.59347.79","article-title":"A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD","volume":"61","author":"Jenner","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.004_bib59","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/ene.14400","article-title":"Clostridium difficile infection and risk of Parkinson\u2019s disease: A Swedish population\u2010based cohort study","volume":"27","author":"Kang","year":"2020","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2014.08.007","article-title":"Review of the emerging treatment of clostridium difficile infection with fecal microbiota transplantation and insights into future challenges","volume":"34","author":"Kassam","year":"2014","journal-title":"Clinics in Laboratory Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/apt.13039","article-title":"Editorial: A simple faecal preparation protocol for faecal microbiota transplantation","volume":"41","author":"Kelly","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12275-018-8032-4","article-title":"Mind-altering with the gut: Modulation of the gut-brain axis with probiotics","volume":"56","author":"Kim","year":"2018","journal-title":"Journal of Microbiology"},{"key":"10.1016\/bs.irn.2025.03.004_bib64","first-page":"969","article-title":"Serotonin in Parkinson\u2019s disease","volume":"31","author":"Kohl","year":"2020"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","article-title":"Diet\u2013microbiota interactions and personalized nutrition","volume":"17","author":"Kolodziejczyk","year":"2019","journal-title":"Nature Reviews. Microbiology"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000534084","article-title":"Stereotactic staged asymmetric bilateral radiofrequency lesioning for Parkinson\u2019s disease","volume":"101","author":"Kostiuk","year":"2023","journal-title":"Stereotactic and Functional Neurosurgery"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/mds.26728","article-title":"The best medicine? The influence of physical activity and inactivity on Parkinson\u2019s disease","volume":"31","author":"LaHue","year":"2016","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4103\/1673-5374.235220","article-title":"Current surgical treatments for Parkinson\u2019s disease and potential therapeutic targets","volume":"13","author":"Lee","year":"2018","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/bs.irn.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2021.07.026","article-title":"Neurogenic and anti-inflammatory effects of probiotics in Parkinson\u2019s disease: A systematic review of preclinical and clinical evidence","volume":"98","author":"Leta","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"issue":"12P2","key":"10.1016\/bs.irn.2025.03.004_bib71","doi-asserted-by":"crossref","DOI":"10.1592\/phco.27.12part2.155S","article-title":"Overview of Parkinson\u2019s disease","volume":"27","author":"Lew","year":"2007","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"7912","key":"10.1016\/bs.irn.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-022-04615-2","article-title":"A tissue-like neurotransmitter sensor for the brain and gut","volume":"606","author":"Li","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2025.03.004_bib73","article-title":"Artificial intelligence-guided gut-microenvironment-triggered imaging sensor reveals potential indicators of Parkinson\u2019s disease","author":"Li","year":"2024","journal-title":"Advanced Science (Weinh)"},{"key":"10.1016\/bs.irn.2025.03.004_bib74","article-title":"Structural and functional dysbiosis of fecal microbiota in chinese patients with Alzheimer\u2019s disease","volume":"8","author":"Ling","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/bs.irn.2025.03.004_bib75","article-title":"Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson\u2019s disease","author":"Liu","year":"2022","journal-title":"Food Research International"},{"key":"10.1016\/bs.irn.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bios.2013.11.013","article-title":"Aptamer biosensor for sensitive detection of toxin A of clostridium difficile using gold nanoparticles synthesized by bacillus stearothermophilus","volume":"54","author":"Luo","year":"2014","journal-title":"Biosensors and Bioelectronics"},{"key":"10.1016\/bs.irn.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.aninu.2021.09.012","article-title":"The interaction among gut microbes, the intestinal barrier and short chain fatty acids","volume":"9","author":"Ma","year":"2022","journal-title":"Animal Nutrition"},{"key":"10.1016\/bs.irn.2025.03.004_bib78","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","article-title":"Probiotics may have beneficial effects in Parkinson\u2019s disease: In vitro evidence","volume":"10","author":"Magistrelli","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27489","article-title":"Mediterranean diet adherence is related to reduced probability of prodromal Parkinson\u2019s disease","volume":"34","author":"Maraki","year":"2019","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JPD-181327","article-title":"Stomaching the possibility of a pathogenic role for helicobacter pylori in Parkinson\u2019s disease","volume":"8","author":"McGee","year":"2018","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2025.03.004_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","article-title":"The role of dopamine in the brain\u2014Lessons learned from Parkinson\u2019s disease","volume":"190","author":"Meder","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/bs.irn.2025.03.004_bib82","doi-asserted-by":"crossref","first-page":"105397","DOI":"10.1016\/j.jff.2022.105397","article-title":"The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson\u2019s disease: A double-blind, placebo-controlled, randomized controlled trial","volume":"100","author":"Mehrabani","year":"2023","journal-title":"Journal of Functional Foods"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib83","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/biomedicines11020541","article-title":"The role of \u03b1-synuclein in the regulation of serotonin system: Physiological and pathological features","volume":"11","author":"Miquel-Rio","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib84","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","article-title":"Probiotics and the treatment of Parkinson\u2019s disease: An update","volume":"42","author":"Mirzaei","year":"2022","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib85","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2351520","article-title":"New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axis","volume":"16","author":"Moradian","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","article-title":"Pathogenic mechanisms of neurodegeneration in Parkinson disease","volume":"33","author":"Mullin","year":"2015","journal-title":"Neurologic Clinics"},{"key":"10.1016\/bs.irn.2025.03.004_bib87","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.47.6_Suppl_3.200S","article-title":"Role of selegiline in combination therapy of Parkinson\u2019s disease","volume":"47","author":"Myllyl\u00e4","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2025.03.004_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2010.00034","article-title":"Brain mitochondrial dysfunction in aging, neurodegeneration and Parkinson\u2019s disease","author":"Navarro","year":"2010","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib89","first-page":"280","article-title":"Endoscopic therapy in inflammatory bowel diseases","volume":"31","author":"Neumann","year":"2015","journal-title":"Viszeralmedizin"},{"key":"10.1016\/bs.irn.2025.03.004_bib90","first-page":"55","article-title":"Parkinson\u2019s disease: Basic pathomechanisms and a clinical overview","volume":"15","author":"Noyce","year":"2017"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib91","first-page":"227","article-title":"Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying","volume":"17","author":"Ogungbenro","year":"2015","journal-title":"American Association of Pharmaceutical Scientists\u00a0Journal"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib92","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein","volume":"12","author":"Ohgita","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2025.03.004_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2015.10.006","article-title":"Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson\u2019s disease","volume":"26","author":"Olson","year":"2016","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.irn.2025.03.004_bib94","doi-asserted-by":"crossref","unstructured":"Om Prakash, P. G., Reddy, B. N. S. K., & Lohith, S. S. M. (2023). Machine learning-based prediction of Parkinson\u2019s disease: A comparative analysis of algorithms. 2023 3rd International Conference on Innovative Mechanisms for Industry Applications (ICIMIA), 1011\u20131018. https:\/\/doi.org\/10.1109\/ICIMIA60377.2023.10426030.","DOI":"10.1109\/ICIMIA60377.2023.10426030"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.004_bib95","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/molecules25112502","article-title":"Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson\u2019s disease","volume":"25","author":"Ostendorf","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.irn.2025.03.004_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.37349\/ent.2021.00007","article-title":"T-cell based immunotherapies for Parkinson\u2019s disease","volume":"1","author":"Pacheco","year":"2021","journal-title":"Explor Neuroprot Ther"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib97","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson\u2019s disease: A meta\u2010analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.004_bib98","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","article-title":"Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage","volume":"26","author":"Paiva","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.004_bib99","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/mdc3.13319","article-title":"The cholinergic brain in Parkinson\u2019s disease","volume":"8","author":"Pasquini","year":"2021","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.irn.2025.03.004_bib100","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.2147\/NDT.S147633","article-title":"Profile of inhaled levodopa and its potential in the treatment of Parkinson\u2019s disease: evidence to date","volume":"14","author":"Patel","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/bs.irn.2025.03.004_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00057","article-title":"Promising effects of neurorestorative diets on motor, cognitive, and gastrointestinal dysfunction after symptom development in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Perez-Pardo","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib102","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40473-017-0129-2","article-title":"Microbes tickling your tummy: The importance of the gut-brain axis in Parkinson\u2019s disease","volume":"4","author":"Perez-Pardo","year":"2017","journal-title":"Current Behavioral Neuroscience Reports"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib103","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-1331.2011.03402.x","article-title":"Oro\u2010buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson\u2019s disease: Preliminary analysis from the French COPARK cohort","volume":"19","author":"Perez\u2010Lloret","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"19","key":"10.1016\/bs.irn.2025.03.004_bib104","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.neuro.29.051605.112824","article-title":"Deep brain stimulation","volume":"29","author":"Perlmutter","year":"2006","journal-title":"Annual Review of Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib106","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.3390\/ijms25084187","article-title":"DNA damage and Parkinson\u2019s disease","volume":"25","author":"Pfeifer","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/brainsci10040242","article-title":"Can Gut microbiota be a good predictor for Parkinson\u2019s disease? A machine learning approach","volume":"10","author":"Pietrucci","year":"2020","journal-title":"Brain Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2217\/nmt-2018-0034","article-title":"Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry","volume":"9","author":"Poewe","year":"2019","journal-title":"Neurodegenerative Disease Management"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in parkinson\u2019s disease (the ONSET PD study)","volume":"30","author":"Pont\u2010Sunyer","year":"2015","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.004_bib110","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1016\/bs.irn.2025.03.004_bib111","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.molmed.2019.07.006","article-title":"An organ-on-a-chip engineered platform to study the microbiota\u2013gut\u2013brain axis in neurodegeneration","volume":"25","author":"Raimondi","year":"2019","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.irn.2025.03.004_bib112","article-title":"From diagnosis to treatment: A comprehensive review of biomarkers and therapeutic advances in Parkinson\u2019s disease","author":"Rangwala","year":"2023","journal-title":"Annals of Neurosciences"},{"key":"10.1016\/bs.irn.2025.03.004_bib113","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neures.2021.01.001","article-title":"Unravelling the role of gut microbiota in Parkinson\u2019s disease progression: Pathogenic and therapeutic implications","volume":"168","author":"Rani","year":"2021","journal-title":"Neuroscience Research"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib114","first-page":"38","article-title":"Serologic testing in celiac disease: Practical guide for clinicians","volume":"62","author":"Rashid","year":"2016","journal-title":"Canadian Family Physician"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/jpm12020266","article-title":"Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson\u2019s disease: A retrospective cohort study","volume":"12","author":"Reden\u0161ek","year":"2022","journal-title":"Journal of Personalized Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib116","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gutjnl-2023-329614","article-title":"Smart capsules for sensing and sampling the gut: Status, challenges and prospects","volume":"73","author":"Rehan","year":"2023","journal-title":"Gut"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib117","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson\u2019s disease","volume":"103","author":"Reich","year":"2019","journal-title":"Medical Clinics of North America"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib118","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short\u2010chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.irn.2025.03.004_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101175","article-title":"The gut\u2013brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders","volume":"46","author":"Richards","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"Suppl 2","key":"10.1016\/bs.irn.2025.03.004_bib120","article-title":"COMT inhibitors in Parkinson\u2019s disease","volume":"26","author":"Rivest","year":"1999","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.004_bib121","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2003.031294","article-title":"Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease 4 years after surgery: Double blind and open label evaluation","volume":"75","author":"Rodriguez-Oroz","year":"2004","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.004_bib123","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.explore.2023.02.007","article-title":"Psychobiotics: Are they the future intervention for managing depression and anxiety? A literature review","volume":"19","author":"Ross","year":"2023","journal-title":"EXPLORE"},{"issue":"2","key":"10.1016\/bs.irn.2025.03.004_bib124","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/bmm-2020-0353","article-title":"Biomarkers of human gut microbiota diversity and dysbiosis","volume":"15","author":"R\u00fcb","year":"2021","journal-title":"Biomarkers in Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib126","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/nu14081567","article-title":"Magnesium orotate and the microbiome-gut-brain axis modulation: New approaches in psychological comorbidities of gastrointestinal functional disorders","volume":"14","author":"Schiopu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/bs.irn.2025.03.004_bib127","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/S1353-8020(08)70021-X","article-title":"Mechanisms of neurodegeneration in idiopathic Parkinson\u2019s disease","volume":"13","author":"Schulz","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib128","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s13311-020-00939-x","article-title":"Surgical treatment of Parkinson\u2019s disease: Devices and lesion approaches","volume":"17","author":"Sharma","year":"2020","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/bs.irn.2025.03.004_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.636545","article-title":"The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis","volume":"13","author":"Shen","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"19","key":"10.1016\/bs.irn.2025.03.004_bib130","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2174\/1568026618666181115100610","article-title":"Recognizing the leaky Gut as a trans-diagnostic target for neuroimmune disorders using clinical chemistry and molecular immunology assays","volume":"18","author":"Simeonova","year":"2018","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"15","key":"10.1016\/bs.irn.2025.03.004_bib131","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/138161208784480072","article-title":"Adenosine A2A receptor antagonists and Parkinson\u2019s disease: State of the art and future directions","volume":"14","author":"Simola","year":"2008","journal-title":"Current Pharmaceutical Design"},{"issue":"10","key":"10.1016\/bs.irn.2025.03.004_bib132","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","article-title":"The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson\u2019s disease model","volume":"14","author":"Siracusa","year":"2015","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"issue":"7","key":"10.1016\/bs.irn.2025.03.004_bib133","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1007\/s12035-023-03809-7","article-title":"Emerging role of long noncoding RNAs in regulating inflammasome-mediated neurodegeneration in Parkinson\u2019s disease","volume":"61","author":"Sivagurunathan","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib134","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/bios10010002","article-title":"Nanomaterials for biosensing lipopolysaccharide","volume":"10","author":"Sondhi","year":"2019","journal-title":"Biosensors"},{"key":"10.1016\/bs.irn.2025.03.004_bib135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain, Behavior, and Immunity"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib136","article-title":"Heart disease, other circulatory diseases, and onset of major depression among community residents in Japan: Results of the world mental health survey Japan 2002\u20132004","author":"Takasaki","year":"2008","journal-title":"Okayama University Medical School"},{"key":"10.1016\/bs.irn.2025.03.004_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.880407","article-title":"In vivo illustration of altered dopaminergic and GABAergic systems in early Parkinson\u2019s disease","volume":"13","author":"Takashima","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib138","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clinical Nutrition"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2011.08.027","article-title":"A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission","volume":"233","author":"Tan","year":"2012","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ejn.14290","article-title":"Immune system responses in Parkinson\u2019s disease: Early and dynamic","volume":"49","author":"Tansey","year":"2019","journal-title":"European Journal of Neuroscience"},{"issue":"43","key":"10.1016\/bs.irn.2025.03.004_bib141","doi-asserted-by":"crossref","first-page":"17087","DOI":"10.1073\/pnas.0704144104","article-title":"Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus","volume":"104","author":"Temel","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib142","article-title":"Parkinson\u2019s disease and bacteriophages as its overlooked contributors","volume":"10","author":"Tetz","year":"2018","journal-title":"Scientific Reports"},{"issue":"33","key":"10.1016\/bs.irn.2025.03.004_bib143","article-title":"Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model","volume":"8","author":"Tetz","year":"2016","journal-title":"Gut Pathogens"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib144","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/microorganisms10081544","article-title":"Role of the gut\u2013brain axis, gut microbial composition, diet, and probiotic intervention in Parkinson\u2019s disease","volume":"10","author":"Thangaleela","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/bs.irn.2025.03.004_bib145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib146","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.28360","article-title":"Cholinergic denervation patterns across cognitive domains in Parkinson\u2019s disease","volume":"36","author":"Van Der Zee","year":"2021","journal-title":"Movement Disorders"},{"issue":"s2","key":"10.1016\/bs.irn.2025.03.004_bib147","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.3233\/JPD-191707","article-title":"The intestinal barrier in Parkinson\u2019s disease: Current state of knowledge","volume":"9","author":"Van IJzendoorn","year":"2019","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib148","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease","volume":"41","author":"Van Nuland","year":"2020","journal-title":"Human Brain Mapping"},{"key":"10.1016\/bs.irn.2025.03.004_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1074736","article-title":"The current state of research for psychobiotics use in the management of psychiatric disorders\u2013A systematic literature review","volume":"14","author":"Vasiliu","year":"2023","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.004_bib150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal microbiota transplantation in neurological disorders","volume":"10","author":"Vendrik","year":"2020","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1144","key":"10.1016\/bs.irn.2025.03.004_bib151","article-title":"Gut microbiota profiling: Metabolomics based approach to unravel compounds affecting human health","volume":"7","author":"Vernocchi","year":"2016","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib152","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JPD-191693","article-title":"A pilot microbiota study in Parkinson\u2019s disease patients versus control subjects, and effects of FTY720 and FTY720-mitoxy therapies in parkinsonian and multiple system atrophy mouse models","volume":"10","author":"Vidal-Martinez","year":"2020","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"S1","key":"10.1016\/bs.irn.2025.03.004_bib153","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.13670","article-title":"Diversity matters \u2013 heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson\u2019s Disease","volume":"139","author":"Vogt Weisenhorn","year":"2016","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"10.1016\/bs.irn.2025.03.004_bib154","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Digestive Diseases and Sciences"},{"issue":"8","key":"10.1016\/bs.irn.2025.03.004_bib155","article-title":"Systematic review: Adverse events of fecal microbiota transplantation","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/bs.irn.2025.03.004_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10505","article-title":"Neuroprotective effect of engineered Clostridiumbutyricum-pMTL007-GLP-1 on Parkinson\u2019s disease mice models via promoting mitophagy","volume":"8","author":"Wang","year":"2023","journal-title":"Bioengineering & Translational Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib157","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1532-5415.2000.tb04732.x","article-title":"Catechol-O-methyltransferase (COMT) inhibitors in Parkinson\u2019s disease","volume":"48","author":"Waters","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib158","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/002383099200500105","article-title":"Side effects of selegiline (Eldepryl)","volume":"5","author":"Waters","year":"1992","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.03.004_bib159","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jnnp.2005.074070","article-title":"Predictors of falls and fractures in bradykinetic rigid syndromes: A retrospective study","volume":"77","author":"Williams","year":"2006","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/bs.irn.2025.03.004_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112523","article-title":"A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing","volume":"168","author":"Woo","year":"2020","journal-title":"Biosensors and Bioelectronics"},{"issue":"28","key":"10.1016\/bs.irn.2025.03.004_bib161","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"\u03b1-Synuclein fibrillogenesis Is nucleation-dependent","volume":"274","author":"Wood","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.004_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10351","article-title":"Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson\u2019s disease in mice by delivering GLP-1 and modulating gut microbiota","volume":"8","author":"Wu","year":"2022","journal-title":"Bioengineering & Translational Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.03.004_bib163","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/10408398.2019.1601848","article-title":"Bioactive phytochemicals","volume":"59","author":"Xiao","year":"2019","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib164","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/biology12010093","article-title":"Parkinson\u2019s disease, it takes guts: The Correlation between intestinal microbiome and cytokine network with neurodegeneration","volume":"12","author":"Xiromerisiou","year":"2023","journal-title":"Biology"},{"issue":"5","key":"10.1016\/bs.irn.2025.03.004_bib165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00002512-199710050-00005","article-title":"Neuropsychiatric adverse effects of antiparkinsonian drugs: Characteristics, evaluation and treatment","volume":"10","author":"Young","year":"1997","journal-title":"Drugs & Aging"},{"issue":"11","key":"10.1016\/bs.irn.2025.03.004_bib166","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation?","volume":"107","author":"Zhang","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/bs.irn.2025.03.004_bib167","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","article-title":"Oxidative stress in Parkinson\u2019s disease: A mechanism of pathogenic and therapeutic significance","volume":"1147","author":"Zhou","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.irn.2025.03.004_bib168","article-title":"Gut microbiota: A novel therapeutic target for Parkinson\u2019s disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Frontiers in Immunology"}],"container-title":["International Review of Neurobiology","Microbiome in Neurological Conditions: Biology, Mechanisms, and Diagnostic Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:54:15Z","timestamp":1748019255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443316487"],"references-count":168,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.03.004","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}